STRENGTHENING PHARMACEUTICAL SUPPLY CHAIN SECURITY IN EUROPE: SERIALIZATION AND EMERGING TECHNOLOGIES
DOI:
https://doi.org/10.46585/pc.2023.2.2493Klíčová slova:
Counterfeit Drugs, Digital Technologies, Blockchain, Pharmaceutical Serialization, RFIDAbstrakt
The pharmaceutical industry's profitability has attracted attention, but it faces challenges from counterfeiters exploiting vulnerabilities worsened by globalization and complex supply chains. In 2019, European authorities introduced regulation EU 2016/161 to enhance drug supply chain security and traceability. By conducting a systematic literature review, this study assesses the effectiveness of the European Drug Serialization system, examining its implementation and the potential benefits of integrating digital technologies like RFID and Blockchain. The aim is to investigate and identify measures contributing to the strengthening of pharmaceutical supply chains against counterfeiting. The research suggests that while serialization is crucial, it may not provide foolproof security, emphasizing the need for additional digital technology integration.
Stažení
Reference
Abugabah, A., Nizamuddin, N. and Abuqabbeh, A. 2020. A review of challenges and barriers implementing RFID technology in the Healthcare sector. Procedia Computer Science, 170, pp. 1003-1010.
Acierno, R., Carata, E., Maffia, M., Mainetti, L. and Patrono, L. 2010. Effects Evaluation of UHF RFID systems on the molecular structure of biological drugs. In 2010 4th International Conference on Bioinformatics and Biomedical Engineering. Chengdu, June 18-20. Chengdu, China: IEEE, pp. 1-4.
Alharthi, S., Cerotti, P. R. and Far, S. M. 2020. An exploration of the role of blockchain in the sustainability and effectiveness of the pharmaceutical supply chain. Journal of Supply Chain and Customer Relationship Management, pp. 1-29.
Argiyantari, B., Simatupang, T. M. and Basri, M. H. 2020. Pharmaceutical supply chain transformation through application of the Lean principle: A literature review. Journal of Industrial Engineering and Management, 13(3), pp. 475-494.
Bansal, D., Malla, S., Gudala, K. and Tiwari, P. 2013. Anti-counterfeit technologies: a pharmaceutical industry perspective. Scientia Pharmaceutica, 81(1), pp. 1-14.
Blackstone, E.A., Fuhr Jr, J.P. and Pociask, S. 2014. The health and economic effects of counterfeit drugs. American health & drug benefits, 7(4), p. 216.
Chen, Y., Yang, O., Sampat, C., Bhalode, P., Ramachandran, R. and Ierapetritou, M. 2020. Digital twins in pharmaceutical and biopharmaceutical manufacturing: a literature review. Processes, 8(9), p. 1088.
Chiacchio, F., Compagno, L., D’Urso, D., Velardita, L. and Sandner, P. 2020. A decentralized application for the traceability process in the pharma industry. Procedia Manufacturing, 42, pp. 362-369.
Chiacchio, F., D’Urso, D., Oliveri, L. M., Spitaleri, A., Spampinato, C. and Giordano, D. 2022. A non-fungible token solution for the track and trace of pharmaceutical supply chain. Applied Sciences, 12(8), p. 4019.
Chircu, A., Sultanow, E. and Saraswat, S. P. 2014. Healthcare RFID in Germany: an integrated pharmaceutical supply chain perspective. Journal of Applied Business Research (JABR), 30(3), pp. 737-752.
EUR-Lex. © 2015. Commission delegated regulation (EU) 2016/161. [Online]. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R0161&from=IT [Accessed: 2022, October 18].
Deisingh, A. K. 2005. Pharmaceutical counterfeiting. Analyst, 130(3), pp. 271-279.
Diazgranados, M. and Funk, V. A. 2013. Utility of QR codes in biological collections. PhytoKeys, (25), p. 21.
EUR-Lex. © 2011. Directive 2011/62/EU of the European Parliament. [Online]. Available at: https://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:174:0074:0087:EN [Accessed: 2022, October 18].
European Commission., Tosseti, P. and Sante, D. G. © 2016. Medicines verification in Europe: What to expect in 2019. [Online]. Available at: https://ec.europa.eu/health/sites/default/files/files/falsified_medicines/201602_stakeholders_workshop_final [Accessed: 2022, October 18].
European Medicines Agency (EMA). © 2021. Falsified Medicines: Overview. [Online]. Available at: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/falsified-medicines-overview [Accessed: 2023, January 14].
European Medicines Verification Organization (EMVO). © 2021. [Online]. Available at: https://emvo-medicines.eu/newdoc/coding-requirements [Accessed: 2023, January 14].
Felix, T., Jordan, J. B., Akers, C., Patel, B. and Drago, D. 2019. Current state of biologic pharmacovigilance in the European Union: improvements are needed. Expert opinion on drug safety, 18(3), pp. 231-240.
Glass, B. D. 2014. Counterfeit drugs and medical devices in developing countries. Research and Reports in Tropical Medicine, pp. 11-22.
González Peña, O. I., López Zavala, M. Á. And Cabral Ruelas, H. 2021. Pharmaceuticals Market, Consumption Trends and Disease Incidence Are Not Driving the Pharmaceutical Research on Water and Wastewater. International Journal of Environmental Research and Public Health, 18(5), p. 2532.
GS1. © 2021. General Specifications [Online]. Available at: https://www.gs1.org/docs/barcodes/GS1_General_Specifications [Accessed: 2022, October 18].
Gupta, P., Hudnurkar, M. and Ambekar, S. 2021. Effectiveness of blockchain to solve the interoperability challenges in healthcare. Cardiometry, (20), 79-87.
Haddara, M. and Staaby, A. 2018. RFID applications and adoptions in healthcare: a review on patient safety. Procedia computer science, 138, pp. 80-88.
Interpol. © 2021. [Online]. Available at: https://www.interpol.int/Crimes/Illicit-goods/Pharmaceutical-crime-operations [Accessed: 2023, September 21].
Jarrett, S., Wilmansyah, T., Bramanti, Y., Alitamsar, H., Alamsyah, D., Krishnamurthy, K. R., Yang, L. and Pagliusi, S. 2020. The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring. Vaccine, 38(52), pp. 8318-8325.
Jochumsen, M. L. and Chaudhuri, A. 2018. Blockchain’s impact on supply chain of a pharmaceutical company. In EUROMA Conference. Budapest, June 24-26. Budapest, Hungary: EUROMA, pp. 1-8.
Kochan, C. G., Nowicki, D. R., Sauser, B. and Randall, W. S. 2018. Impact of cloud-based information sharing on hospital supply chain performance: A system dynamics framework. International Journal of Production Economics, 195, pp. 168-185.
Kootstra, J. and Kleinhout-Vliek, T. 2021. Implementing pharmaceutical track-and-trace systems: a realist review. BMJ global health, 6(Suppl 3), p. e003755.
Kshetri, N. 2017. Can blockchain strengthen the internet of things?. IT professional, 19(4), pp. 68-72.
Kshetri, N. 2018. 1 Blockchain’s roles in meeting key supply chain management objectives. International Journal of information management, 39, pp. 80-89.
Mackey, T. K. and Nayyar, G. 2017. A review of existing and emerging digital technologies to combat the global trade in fake medicines. Expert opinion on drug safety, 16(5), pp. 587-602.
Mackey, T. K., Cuomo, R., Guerra, C. and Liang, B. A. 2015. After counterfeit Avastin®—what have we learned and what can be done?. Nature Reviews Clinical Oncology, 12(5), pp. 302-308.
Markarian, J. 2014. Implementing supply-chain security. Pharmaceutical Technology, 37(8).
Mettler, M. 2016. Blockchain technology in healthcare: The revolution starts here. In 2016 IEEE 18th international conference on e-health networking, applications and services (Healthcom). Munich, September 14-16. Munich, Germany: IEEE, pp. 1-3.
MG, M. V., Pramod Kumar, T. M. and Venkatesh, M. P. 2019. Reverse logistic management in pharmaceutical industry – A supply chain analysis. Journal of Global Trends in Pharmaceutical Sciences, 10(3), pp. 6577-6582.
Nabiyeva, A. and Wu, D. Z. 2017. Serialization of prescription drugs in the USA: a centralized view (Doctoral dissertation, Massachusetts Institute of Technology).
Nalam, R. 2023. Systematic review of pharmaceutical drugs serialization. International Journal of Research Publications, 120(1), pp. 9-9.
Nayyar, G. M., Breman, J. G., Mackey, T. K., Clark, J. P., Hajjou, M., Littrell, M. and Herrington, J. E. 2019. Falsified and substandard drugs: stopping the pandemic. The American journal of tropical medicine and hygiene, 100(5), p. 1058.
OECD and EUIPO. © 2020. Trade in counterfeit pharmaceutical products, illicit trade. OECD Publishing, Paris. [Online]. Available at: https://doi.org/10.1787/a7c7e054-en [Accessed: 2023, September 18].
Pagonidis, T., Sapuric, S. and Lois, P. 2020. Assessing the implementation of serialisation in pharmaceutical industry in Greece: a qualitative approach. Journal for Global Business Advancement, 13(1), pp. 4-31.
Parmaksiz, K., Pisani, E. and Kok, M. O. 2020. What makes a national pharmaceutical track and trace system succeed? Lessons from Turkey. Global Health: Science and Practice, 8(3), pp. 431-441.
Pascu, G. A., Hancu, G. and Rusu, A. 2020. Pharmaceutical serialization, a global effort to combat counterfeit medicines. Acta Marisiensis-Seria Medica, 66(4), pp. 132-139.
Patton, S. 2006. Cracks in the pharmaceutical supply chain: Faced with a rising tide of counterfeit and deceptively priced drugs, pharmaceutical companies are turning to technologies such as RFID to better track medications through a convoluted supply chain. CIO-FRAMINGHAM MA-, 19(7), p. 48.
Pedroso, M. C. and Nakano, D. 2009. Knowledge and information flows in supply chains: A study on pharmaceutical companies. International journal of production economics, 122(1), pp. 376-384.
Pharmaceutical Security Institute (PSI). © 2022. [Online]. Available at: https://www.psi-inc.org/incident-trends [Accessed: 2023, September 18].
Piper, N. 2019. Implementing global standards to ensure end to end FMD compliance. European Pharmaceutical Review, 24(3), pp. 62-64.
Pisa, M. and McCurdy, D. © 2019. Improving global health supply chains through traceability. Center for Global Development. [Online]. Available at: https://www.cgdev.org/sites/default/files/improving-global-health-supply-chains-through-traceability [Accessed: 2023, August 21].
Raijada, D., Wac, K., Greisen, E., Rantanen, J. and Genina, N. 2021. Integration of personalized drug delivery systems into digital health. Advanced drug delivery reviews, 176, p. 113857.
Rajora, N. 2022. Dynamics of Pharmaceutical Drugs Serialization. Universal Journal of Pharmacy and Pharmacology, 1(1), pp. 43-49.
Raju, M. H., Ahmed, M. U. and Ahad, M. A. R. 2020. Security analysis and a potential layer to layer security solution of medical cyber-physical systems. A Handbook of Internet of Things in Biomedical and Cyber Physical System, pp. 61-86.
Rasheed, H., Höllein, L. and Holzgrabe, U. 2018. Future information technology tools for fighting substandard and falsified medicines in low-and middle-income countries. Frontiers in pharmacology, 9, p. 995.
Rivers, M. 2022. Serialization and Aggregation from a Manufacturing Perspective. Pharmaceutical Technology, 46(2), pp. 34-35.
Rossetti, C. L., Handfield, R. and Dooley, K. J. 2011. Forces, trends, and decisions in pharmaceutical supply chain management. International Journal of Physical Distribution & Logistics Management, 41(6), pp. 601-622.
Saha, E., Rathore, P., Parida, R. and Rana, N. P. 2022. The interplay of emerging technologies in pharmaceutical supply chain performance: An empirical investigation for the rise of Pharma 4.0. Technological Forecasting and Social Change, 181, p. 121768.
Sarkar, S. 2022. Pharmaceutical Serialization: A Challenge for Small Manufacturers. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 8(4), pp. 174-181.
Sarkar, S. 2023. Why Pharmaceutical Drug Traceability in the US Needs a Centralized Cloud-Based Platform. Current Journal of Applied Science and Technology, 42(21), pp. 1-11.
Schraml, R., Debiasi, L. and Uhl, A. 2018. Real or fake: Mobile device drug packaging authentication. In Proceedings of the 6th ACM workshop on information hiding and multimedia security. Innsbruck, June 20-22. Innsbruck, Austria: University of Salzburg, pp. 121-126.
Soon, J. M. and Manning, L. 2019. Developing anti-counterfeiting measures: The role of smart packaging. Food Research International, 123, pp. 135-143.
Stobie, C. 2015. The hidden challenges of pharmaceutical serialization by Domino Printing Sciences. Journal of Generic Medicines, 12(1), pp. 11-16.
Sturtevant, P. 2017. Drug serialization for DSCSA compliance benefits everyone. Pharmaceutical Executive, 37(9).
Sylim, P., Liu, F., Marcelo, A. and Fontelo, P. 2018. Blockchain technology for detecting falsified and substandard drugs in distribution: pharmaceutical supply chain intervention. JMIR research protocols, 7(9), e10163.
Valcheva, K. 2021. The Impact of the European Directive Against Falsified Medicines on the Pharmaceutical Wholesalers in Bulgaria. Journal of IMAB–Annual Proceeding Scientific Papers, 27(1), pp. 3598-3603.
Whyte, J. © 2017. Pharmaceutical serialization: an implementation guide. Global Serialization Lead, Rockwell Automation. [Online] Available at: https://literature.rockwellautomation.com/idc/groups/literature/documents/wp/lifesc-wp001_-en-p.pdf [Accessed: 2023, September 21].
Widengren, S. 2017. Serialization: The final countdown. Pharmaceutical Technology Europe, 1, pp. 14-15.
World Health Organization (WHO). © 2018. Available at: https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products [Accessed: 2022, October 18].
Yao, W., Chu, C. H. and Li, Z. 2010. The use of RFID in healthcare: Benefits and barriers. In 2010 IEEE International Conference on RFID-Technology and Applications. Guangzhou, June 17-19. Guangzhou, China: IEEE, pp. 128-134.
Yao, W., Chu, C. H. and Li, Z. 2012. The adoption and implementation of RFID technologies in healthcare: a literature review. Journal of medical systems, 36(6), pp. 3507-3525.
Yli-Huumo, J., Ko, D., Choi, S., Park, S. and Smolander, K. 2016. Where is current research on blockchain technology?—a systematic review. PloS one, 11(10), p. e0163477.
You, M., Lin, M., Wang, S., Wang, X., Zhang, G., Hong, Y., Dong, Y. and Xu, F. 2016. Three-dimensional quick response code based on inkjet printing of upconversion fluorescent nanoparticles for drug anti-counterfeiting. Nanoscale, 8(19), pp. 10096-10104.
Zakari, N., Al-Razgan, M., Alsaadi, A., Alshareef, H., Al saigh, H., Alashaikh, L., Alharbi, M., Alomar, R. and Alotaibi, S. 2022. Blockchain technology in the pharmaceutical industry: a systematic review. PeerJ Computer Science, 8, p. e840.
Zheng, Z., Xie, S., Dai, H., Chen, X. and Wang, H. 2017. An overview of blockchain technology: Architecture, consensus, and future trends. In 2017 IEEE international congress on big data (BigData congress). Honolulu, June 25-30. Honolulu, USA: IEEE pp. 557-564.
Stahování
Publikováno
Jak citovat
Číslo
Sekce
Licence
Copyright (c) 2023 Vikram Chowdhary, Marek Vinš
Tato práce je licencována pod Mezinárodní licencí Creative Commons Attribution 4.0 .
Přijat 2023-11-27
Publikován 2023-12-30
